Fluorescent base analogues' usage in the characterization of nucleic acid molecules and their interactions

• US 7,851,152 B2
• Filed: 09/23/2005
• Issued: 12/14/2010
• Est. Priority Date: 09/25/2004
• Status: Active Grant

• Current Assignee: Yaodong Chen
• Original Assignee: Yaodong Chen
• Inventors: Chen, Yaodong
• Primary Examiner(s): WHISENANT, ETHAN C
• Application Number:
  US11/234,762
• Publication Number:
  US 20080020378A1
• Time in Patent Office: 1,908 Days
• Field of Search: 435/6, 536/23.1, 536/24.3
• US Class Current: 435/6.14
• CPC Class Codes: C12Q 1/6813 Hybridisation assays
• CPC Class Codes: C12Q 2525/117 incorporating modified base
• CPC Class Codes: C12Q 2563/107 fluorescence

Abstract

This invention provides methods, apparatus and kits for the quantitative and qualitative characterization of the nucleic acid molecule'"'"'s behavior by modify the nucleic acid molecules to incorporate selected fluorescent base analogues (FBAs). The methods generally place one or more fluorescent base analogue into a nucleic acid molecule (e.g., an oligonucleotide) to replace the corresponding normal base(s), arrange fluorescent base analogues as intrinsic fluorescent probes by using direct excitation, indirect excitation, and excimer emission labeling schemes, introducing so modified nucleic acid molecules into the matrix with interested condition and measuring the fluorescent properties of the modified nucleic acid molecules at the specific emission wavelength of FBA(s). The apparatus is designed to irradiate the FBA(s) incorporated nucleic acid molecule at a wavelength in the range of 240 nm-280 nm and detect the fluorescent activities at the specific emission wavelength of the respective FBA(s). The kit provides oligonucleotides modified by multiple FBAs in the position of critical portions. It utilizes simultaneous indirect excitation labeling scheme for qualitative and quantitative investigation of nucleic acid molecules'"'"' interaction in vitro and in vivo.

Claims

1. A method of detecting the structures and interactions of a nucleic acid molecule, comprising:

placing in said nucleic acid molecule or substituting corresponding nucleotide(s) of said nucleic acid molecule with one or multiple fluorescent nucleotide analogue(s);

introducing so modified nucleic acid molecule into a target matrix or medium so as to subject the nucleic acid molecule to interactions with components in the matrix or medium; and

detecting the structures and activities of said nucleic acid molecule by measuring fluorescence properties of the fluorescent base analogue(s) in said nucleic acid molecule at the fluorescent base analogue'"'"'s respective emission wavelength by indirect excitation of nearby natural bases of said nucleic acid molecule at a wavelength in the range of 240 nm to 280 nm, in which the fluorescent base analogue is 2-aminopurine, and the emission wavelength is in the range of 350 nm to 380 nm.

2. A method of detecting the structures and interactions of a nucleic acid molecule, comprising:

placing in said nucleic acid molecule or substituting corresponding nucleotide(s) of said nucleic acid molecule with one or multiple fluorescent nucleotide analogue(s);

introducing so modified nucleic acid molecule into a target matrix or medium so as to subject the nucleic acid molecule to interactions with components in the matrix or medium; and

detecting the structures and activities of said nucleic acid molecule by measuring fluorescence properties of the fluorescent base analogue(s) in said nucleic acid molecule at the fluorescent base analogue'"'"'s respective emission wavelength by indirect excitation of nearby natural bases of said nucleic acid molecule at a wavelength in the range of 240 nm to 280 nm,

in which the fluorescent base analogue is 4-amino-6-methyl-pteridone, and the emission wavelength is in the range of 410 nm to 450 nm.

3. A method of detecting the structures and interactions of a nucleic acid molecule, comprising:

placing in said nucleic acid molecule or substituting corresponding nucleotide(s) of said nucleic acid molecule with one or multiple fluorescent nucleotide analogue(s);

introducing so modified nucleic acid molecule into a target matrix or medium so as to subject the nucleic acid molecule to interactions with components in the matrix or medium; and

detecting the structures and activities of said nucleic acid molecule by measuring fluorescence properties of the fluorescent base analogue(s) in said nucleic acid molecule at the fluorescent base analogue'"'"'s respective emission wavelength by indirect excitation of nearby natural bases of said nucleic acid molecule at a wavelength in the range of 240 nm to 280 nm,

in which the fluorescent base analogue is 6-methyl-isoxanthopterin, and the emission wavelength is in the range of 410 nm to 450 nm.

4. A method of detecting the structures and interactions of a nucleic acid molecule, comprising:

placing in said nucleic acid molecule or substituting corresponding nucleotide(s) of said nucleic acid molecule with one or multiple fluorescent nucleotide analogue(s);

introducing so modified nucleic acid molecule into a target matrix or medium so as to subject the nucleic acid molecule to interactions with components in the matrix or medium; and

detecting the structures and activities of said nucleic acid molecule by measuring fluorescence properties of the fluorescent base analogue(s) in said nucleic acid molecule at the fluorescent base analogue'"'"'s respective emission wavelength by indirect excitation of nearby natural bases of said nucleic acid molecule at a wavelength in the range of 240 nm to 280 nm,

in which the fluorescent base analogue is pyrrolo-(d)C, and the emission wavelength is in the range of 440 nm to 480 nm.

5. A method of detecting the structures and interactions of a nucleic acid molecule, comprising:

placing in said nucleic acid molecule or substituting corresponding nucleotide(s) of said nucleic acid molecule with one or multiple fluorescent nucleotide analogue(s);

introducing so modified nucleic acid molecule into a target matrix or medium so as to subject the nucleic acid molecule to interactions with components in the matrix or medium; and

detecting the structures and activities of said nucleic acid molecule by measuring fluorescence properties of the fluorescent base analogue(s) in said nucleic acid molecule at the fluorescent base analogue'"'"'s respective emission wavelength by indirect excitation of nearby natural bases of said nucleic acid molecule at a wavelength in the range of 240 nm to 280 nm,

wherein the multiple fluorescent nucleotide analogues incorporated comprises 2-aminopurine, 6-methyl-isoxanthopterin, and pyrrolo-(d)C; and

wherein detecting the structures and activities of said nucleic acid molecule by simultaneously measuring fluorescence properties of 2-aminopurine, 6-methyl -isoxanthopterin, and pyrrolo-(d)C in said nucleic acid molecule at 2-aminopurine'"'"'s emission wavelength around 370 nm, at 6-methyl-isoxanthopterin'"'"'s emission wavelength around 430 nm and at pyrrolo-(d)C'"'"'s emission wavelength around 460 nm.

6. A kit for the method of claim 5 comprising at least one piece of oligonucleotide incorporating three different fluorescent base analogues at three specific positions selected from the group of positions consisting of:

1) 2-aminopurine at the 5′

end portion, 6-methyl-isoxanthopterin at the middle portion, and pyrrolo-(d)C at the 3′

end portion of the oligonucleotide;

2) 2-aminopurine at the 3′

end portion, 6-methyl-isoxanthopterin at the 5′

end portion, and pyrrolo-(d)C at the middle portion of the oligonucleotide;

3) 2-aminopurine at the middle portion, 6-methyl-isoxanthopterin at the 3′

end portion, and pyrrolo-(d)C at the 5′

end portion of the oligonucleotide;

4) 2-aminopurine at the 5′

end portion, 6-methyl -isoxanthopterin at the 3′

end portion and pyrrolo-(d)C at the middle portion of the oligonucleotide;

5) 2-aminopurine at the 3′

end portion, 6-methyl -isoxanthopterin at the middle portion and pyrrolo-(d)C at the 5′

end portion of the oligonucleotide; and

6) 2-aminopurine at the middle portion, 6-methyl-isoxanthopterin at the 5′

end portion and pyrrolo-(d)C at the 3′

end portion of the oligonucleotide.

7. The kit in claim 6, wherein the fluorescent base analogue incorporated oligonucleotides are double strand.

8. The kit in claim 6, further includes a suitable buffer for the stability and viability of the oligonucleotides.